Elutia (ELUT) vs Rapid Micro Biosystems (RPID)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Elutia (ELUT) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 6.9% versus a loss of 75.4%. Over five years, ELUT leads with a -84.8% price change compared with -94.9% for RPID. Rapid Micro Biosystems is the larger company by market cap ($43.2 million vs $36.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELUT | RPID |
|---|---|---|
| Share price | $0.8273 | $0.8617 |
| Market cap | $36.64M | $43.22M |
| 1-day change | +0.88% | -4.01% |
| YTD return | +19.38% | -70.29% |
| 1-year return | -6.94% | -75.38% |
| 5-year return | -84.82% | -94.88% |
| EPS (TTM) | $-0.64 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.39 | $4.94 |
| 52-week low | $0.50 | $0.826 |
| Distance from 52-week high | -40.27% | -82.56% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +504.38% | +567.29% |
| Average volume | 185.82K | 271.93K |
| Shares outstanding | 44.29M | 45.66M |
| Employees | 25 | 171 |
| Sector | Health Care | Industrials |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELUT has outperformed RPID by 68.4 percentage points over the past year.
- The two companies sit in different sectors: Elutia in Health Care and Rapid Micro Biosystems in Industrials.
About Elutia
ELUT stock →Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 25 employees
About Rapid Micro Biosystems
RPID stock →Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 171 employees
ELUT vs RPID FAQ
Which is bigger, Elutia or Rapid Micro Biosystems?
Rapid Micro Biosystems (RPID) is larger, with a market capitalization of $43.22M compared with $36.64M for Elutia (ELUT).
Which stock has performed better over the past year, ELUT or RPID?
ELUT returned -6.94% over the past 12 months, compared with -75.38% for RPID (price return, excluding dividends). Past performance does not predict future results.
Are Elutia and Rapid Micro Biosystems in the same industry?
No. Elutia is in the Health Care sector, while Rapid Micro Biosystems is in Industrials.